February 2025 Ad-Hoc Prescription Drug Affordability Board Meeting

• Date and time: February 26th, 2025 8:00 am

Public Comment

The Board has set aside an opportunity for public comment during the meeting. Public comments must concern an agenda item and are limited to one minute and thirty seconds per comment. If you are interested in registering to make a public comment, please email [email protected]​ no later than the close of business on Friday, February 21, 2025, and provide:

1. Your name
2. Your address
3. The agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail.

Written Comment

The public may also submit written comments on the Board's pending decisions, or general comments regarding the Board's work, to [email protected]​​​. Please submit any written comments, concerning this agenda no later than the close of business on Friday, February 21, 2025. Please utilize the subject line “February 2025 Board Comments.”

Agenda and Meeting Materials

• ​​Agenda (Revised 2/19/2025) - PDF - 157.66 KB
• Minutes - PDF - 93.96 KB
• Meeting Recording
• ​Work Session​ concerning Comments Received on Proposed Regulations (Presentation) - PDF - 287.36 KB
• Written Comment ​Packet - PDF - 128.86 KB

Comments received from the following:

• Mary P Howell, M.D., Rheumatology Consultants
• Steven J. Klein, M.D., Rheumatology Consultants
  ​​​